D.E. Shaw & Co’s Krystal Biotech KRYS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.61M | Sell |
11,727
-38,165
| -76% | -$5.25M | ﹤0.01% | 2014 |
|
|
2025
Q1 | $9M | Buy |
49,892
+42,465
| +572% | +$7.66M | 0.01% | 1055 |
|
|
2024
Q4 | $1.16M | Sell |
7,427
-1,919
| -21% | -$301K | ﹤0.01% | 2069 |
|
|
2024
Q3 | $1.7M | Sell |
9,346
-1,700
| -15% | -$309K | ﹤0.01% | 1880 |
|
|
2024
Q2 | $2.03M | Sell |
11,046
-70,981
| -87% | -$13M | ﹤0.01% | 1798 |
|
|
2024
Q1 | $14.6M | Buy |
82,027
+14,886
| +22% | +$2.65M | 0.01% | 741 |
|
|
2023
Q4 | $8.33M | Buy |
67,141
+11,384
| +20% | +$1.41M | 0.01% | 953 |
|
|
2023
Q3 | $6.47M | Buy |
55,757
+45,962
| +469% | +$5.33M | 0.01% | 1040 |
|
|
2023
Q2 | $1.15M | Buy |
9,795
+4,200
| +75% | +$493K | ﹤0.01% | 2009 |
|
|
2023
Q1 | $448K | Sell |
5,595
-805
| -13% | -$64.4K | ﹤0.01% | 2553 |
|
|
2022
Q4 | $507K | Sell |
6,400
-1,700
| -21% | -$135K | ﹤0.01% | 2708 |
|
|
2022
Q3 | $565K | Hold |
8,100
| – | – | ﹤0.01% | 2820 |
|
|
2022
Q2 | $532K | Buy |
8,100
+4,291
| +113% | +$282K | ﹤0.01% | 3012 |
|
|
2022
Q1 | $253K | Buy |
+3,809
| New | +$253K | ﹤0.01% | 3517 |
|
|
2021
Q4 | – | Sell |
-13,571
| Closed | -$709K | – | 4098 |
|
|
2021
Q3 | $709K | Buy |
13,571
+6,331
| +87% | +$331K | ﹤0.01% | 2668 |
|
|
2021
Q2 | $492K | Buy |
+7,240
| New | +$492K | ﹤0.01% | 2894 |
|